(Q24200887)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

meta-analysis

0 references

title

Interventions for smoking cessation and reduction in individuals with schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

1 reference

3

Angela C Webster

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Daniel T Tsoi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mamta Porwal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

28 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

CD007253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

24 February 2020

cites work

1 reference

12 December 2020

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

12 December 2020

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia

1 reference

12 December 2020

Double-blind study of clozapine dose response in chronic schizophrenia

1 reference

12 December 2020

Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland

1 reference

12 December 2020

Current models of nicotine dependence: what is known and what is needed to advance understanding of tobacco etiology among youth

1 reference

12 December 2020

Causes of the excess mortality of schizophrenia

1 reference

12 December 2020

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

12 December 2020

Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia

1 reference

12 December 2020

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

1 reference

12 December 2020

Incidence of cancer among persons with schizophrenia and their relatives

1 reference

12 December 2020

Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective

1 reference

12 December 2020

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

1 reference

12 December 2020

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

1 reference

12 December 2020

Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research

1 reference

12 December 2020

Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia

1 reference

12 December 2020

Balancing benefits and harms in health care.

1 reference

12 December 2020

High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking.

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

1 reference

12 December 2020

Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders.

1 reference

12 December 2020

The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia

1 reference

12 December 2020

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

1 reference

12 December 2020

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction

1 reference

12 December 2020

Financial implications of cigarette smoking among individuals with schizophrenia

1 reference

12 December 2020

Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence

1 reference

12 December 2020

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

1 reference

12 December 2020

Outcome criteria in smoking cessation trials: proposal for a common standard.

1 reference

12 December 2020

Group behaviour therapy programmes for smoking cessation

1 reference

12 December 2020

Individual behavioural counselling for smoking cessation

1 reference

12 December 2020

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia

1 reference

12 December 2020

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

1 reference

12 December 2020

A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia

1 reference

12 December 2020

Does clozapine decrease smoking?

1 reference

12 December 2020

Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.

1 reference

12 December 2020

Operant Conditioning of Activities of Daily Living on a Psychogeriatric Ward: A Simple Method

1 reference

12 December 2020

Self-help interventions for smoking cessation

1 reference

12 December 2020

The feasibility of smoking reduction: an update

1 reference

12 December 2020

Smoking bans in psychiatric inpatient settings? A review of the research

1 reference

12 December 2020

Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function

1 reference

12 December 2020

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

1 reference

12 December 2020

Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved.

1 reference

12 December 2020

Telephone counselling for smoking cessation

1 reference

12 December 2020

A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder

1 reference

12 December 2020

Does smoking reduction increase future cessation and decrease disease risk? A qualitative review

1 reference

12 December 2020

Antidepressants for smoking cessation

1 reference

12 December 2020

Characteristics of smokers with a psychotic disorder and implications for smoking interventions

1 reference

12 December 2020

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia

1 reference

12 December 2020

Exacerbation of schizophrenia by varenicline

1 reference

12 December 2020

A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.

1 reference

12 December 2020

Galantamine for the treatment of cognitive impairments in people with schizophrenia

1 reference

12 December 2020

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia

1 reference

12 December 2020

A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses

1 reference

12 December 2020

Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type

1 reference

12 December 2020

Physician advice for smoking cessation

1 reference

12 December 2020

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia

1 reference

12 December 2020

Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia

1 reference

12 December 2020

Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization

1 reference

12 December 2020

Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia

1 reference

12 December 2020

Predictors of early abstinence in smokers with schizophrenia

1 reference

12 December 2020

Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia

1 reference

12 December 2020

Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption

1 reference

12 December 2020

Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia

1 reference

12 December 2020

Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study

1 reference

12 December 2020

Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study

1 reference

12 December 2020

Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder

1 reference

12 December 2020

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

1 reference

12 December 2020

Transdermal nicotine and smoking behavior in psychiatric patients

1 reference

12 December 2020

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

1 reference

12 December 2020

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

1 reference

12 December 2020

Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia

1 reference

12 December 2020

Cigarette smoking and mortality risk in people with schizophrenia

1 reference

12 December 2020

Motivational interviewing for smoking cessation

1 reference

12 December 2020

Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial

1 reference

12 December 2020

Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Smoking outcome by psychiatric history after behavioral and varenicline treatment

1 reference

12 December 2020

Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis.

1 reference

12 December 2020

Smoking cessation in severe mental illness: what works?

1 reference

12 December 2020

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

1 reference

12 December 2020

Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia

1 reference

12 December 2020

Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders

1 reference

12 December 2020

Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Smoking cessation in women with severe mental illness: exploring the role of exercise as an adjunct treatment

1 reference

12 December 2020

Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study

1 reference

12 December 2020

An electronic decision support system to motivate people with severe mental illnesses to quit smoking

1 reference

12 December 2020

Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia

1 reference

12 December 2020

A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups

1 reference

12 December 2020

Competitions and incentives for smoking cessation

1 reference

12 December 2020

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis

1 reference

12 December 2020

Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions

1 reference

12 December 2020

Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity

1 reference

12 December 2020

Smoking, quitting, and psychiatric disease: a review

1 reference

12 December 2020

A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol.

1 reference

12 December 2020

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand

1 reference

12 December 2020

Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Suicidal behavior and depression in smoking cessation treatments

1 reference

12 December 2020

Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study

1 reference

12 December 2020

High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia.

1 reference

12 December 2020

Nicotine receptor partial agonists for smoking cessation

1 reference

12 December 2020

Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients

1 reference

12 December 2020

Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial

1 reference

12 December 2020

Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies

1 reference

12 December 2020

Combined pharmacotherapy and behavioural interventions for smoking cessation

1 reference

12 December 2020

Nicotine replacement therapy for smoking cessation

1 reference

12 December 2020

Effects of Topiramate on Smoking in Patients with Schizoaffective Disorder, Bipolar Type: Response to Khazaal and Zullino

1 reference

12 December 2020

Effects of smoking on fluphenazine clearance in psychiatric inpatients

1 reference

12 December 2020

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

12 December 2020

Haloperidol increases smoking in patients with schizophrenia

1 reference

12 December 2020

Nicotine dependence and schizophrenia

1 reference

12 December 2020

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

1 reference

12 December 2020

Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study.

1 reference

12 December 2020

Schizophrenia, sensory gating, and nicotinic receptors

1 reference

12 December 2020

A pilot study examining the acute effects of exercise on cigarette cravings and affect among individuals with serious mental illness

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD007253.PUB3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD007253.PUB3

2 references

Consolidated OpenCitations Corpus – April 2017

3865959

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

3865959

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23450574%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

PubMed publication ID

23450574

2 references

Consolidated OpenCitations Corpus – April 2017

3865959